Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Gen Hosp Psychiatry. 2017 Nov 8;50:104–110. doi: 10.1016/j.genhosppsych.2017.11.001

Table 3.

Linear regression analysis examining the association between medical cannabis use and risk of prescription opioid misuse.

R2 Unadjusted B (SE) Adjusted β* 95% CI p-value
Risk of prescription opioid misuse 0.21
 Age − 0.07 (0.03) −0.11 − 0.14 – − 0.01 0.031
 Gender    1.89 (0.72)    0.13    0.47 – 3.31 0.009
 Medical comorbidity    0.44 (0.14)    0.16    0.15 – 0.72 0.003
 Depression    0.30 (0.07)    0.22    0.16 – 0.43 <0.001
 Prescription opioid dose − 0.01 (0.01) −0.05 − 0.04 – 0.01 0.332
 Pain intensity    0.08 (0.27)    0.16    0.03 – 0.14 0.002
 Cannabis use    3.21 (0.94)    0.17    1.36 – 5.05 0.001

Note: Adjusted models controlled for age, gender, depression, pain intensity, prescription opioid dose, and medical comorbidity score.